Views & Analysis ‘No going back’ for clinical trials after COVID Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result.
News As drug costs for US employers rise, some cut GLP-1s from pl... Pharmacy now represents 25% of employer healthcare spending, and employers are turning to DTC models and nontraditional PBMs to cut costs.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.